Altered dendritic cell subset distribution in patients with Parkinson's disease: Impact of CMV serostatus

MLA

David Goldeck, et al. “Altered Dendritic Cell Subset Distribution in Patients with Parkinson’s Disease: Impact of CMV Serostatus.” Journal of Neuroimmunology, vol. 290, Jan. 2016, pp. 60–65. EBSCOhost, https://doi.org/10.1016/j.jneuroim.2015.11.008.

APA

David Goldeck, Daniela Berg, Lilly Oettinger, Graham Pawelec, & Walter Maetzler. (2016). Altered dendritic cell subset distribution in patients with Parkinson’s disease: Impact of CMV serostatus. Journal of Neuroimmunology, 290, 60–65. https://doi.org/10.1016/j.jneuroim.2015.11.008

Chicago

David Goldeck, Daniela Berg, Lilly Oettinger, Graham Pawelec, and Walter Maetzler. 2016. “Altered Dendritic Cell Subset Distribution in Patients with Parkinson’s Disease: Impact of CMV Serostatus.” Journal of Neuroimmunology 290 (January): 60–65. doi:10.1016/j.jneuroim.2015.11.008.